Last update 01 Nov 2024
Ningxia Medical University

Ningxia Medical University

Education|
1958|
Ningxia Huizi Zizhiqu, China

Overview

Tags

Other Diseases
Neoplasms
Nervous System Diseases
Small molecule drug
Recombinant polypeptide
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug3
Recombinant polypeptide1
Chemical drugs1
Top 5 TargetCount
PI3K family(Phosphatidylinositol 3-kinase family)1
NAE(NEDD8 activating enzyme)1
TGFBR2(Transforming growth factor beta receptor 2)1
RIPK1(Receptor-interacting serine/threonine-protein kinase 1)1

Related

6
Drugs associated with Ningxia Medical University
CJJ300
Target
TGFBR2
Mechanism
TGFBR2 inhibitors
Active Org.
Ningxia Medical UniversityNingxia Medical University
Originator Org.
Ningxia Medical UniversityNingxia Medical University
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
SY1
Target
RIPK1
Mechanism
RIPK1 inhibitors
Active Org.
Ningxia Medical UniversityNingxia Medical University
Originator Org.
Ningxia Medical UniversityNingxia Medical University
Active Indication
Epilepsy [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
ACZ2
Target-
Mechanism-
Active Org.
Ningxia Medical UniversityNingxia Medical University
Originator Org.
Zhongnan hospital of wuhan university
Active Indication
Inflammation
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Ningxia Medical University
Login to view more data
0 Patents (Medical) associated with Ningxia Medical University
Login to view more data
100 Deals associated with Ningxia Medical University
Login to view more data
100 Translational Medicine associated with Ningxia Medical University
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
4
Preclinical
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SY1
 ( RIPK1 )		Epilepsy
More
Preclinical
CJJ300
 ( TGFBR2 )		Neoplasms
More
Preclinical
ACZ2
Inflammation
More
Preclinical
ZM223
 ( NAE )		Neoplasms
More
Preclinical
CN114181294
 ( PI3K family )		Rare Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free